$TRON The chain of non-denial speaks volumes that a thousand detractors cannot. In fact, the only denial to date, has been by Rene and Toron, and was in regards to a fabricated press release constructed and paid for by someone outside of the company.
So getting back to the proof in the silence, there have been a multitude of press releases and updates put out by Toron that mention their dealings with, and acquisition of, InMed. InMed has never once called for a retraction, nor has InMed ever filed suit against Toron, nor has InMed ever issued an independent press release in defense of false claims.
Not only has InMed shown itself comfortable with Toron's disclosures, Flagship has also done the same on the financing end of things. Both InMed and Flagship have signed documentation confirming Toron's public statements, with the respective CEO signatures and letterhead also being posted and shared. No denial or retraction or suit has emerged and been proven legitimate.
Silence has also come in the form of the rvom110 twitter account belonging to the Toron's CEO. https://twitter.com/rvom110/with_replies
The original account for Toron was the IncToron account. I suspect this account will become more active in times to come. https://twitter.com/IncToron/with_replies
Both accounts are mentioned due to the fact that IncToron was mentioned by the rvom110 account in the majority of its Tweets, which would therefore signal an alert which the original Toron could spot from a mile away and blind.
If Rene put out a formal retraction of a falsified PR, there is no way he would not use the IncToron account to publicly claim impersonation on the part of the rvom110 account if it were indeed fraudulent. And to top the evidence in silence off on that part, one of the longs posted a request for verification of the rvom110 account on the Toron website forum. This was posted five days ago, and is obviously monitored by Toron's management. No denial ever came out on behalf of the CEO or company.
So if IncToron is not speaking out against rvom110, nor is the CEO on the company website forum, the silence does the talking. And if InMed has not spoken out in over twelve months of having their deal disclosed and detailed by Toron, nor have they stated falsification of the InMed CEO's letter of confirmation regarding the finalization of the long publicized acquisition, then the silence again does the talking. Additionally, Flagship has not issued any statement or release claiming that Toron's public dissemination of their relationship is false, nor has it done anything similar regarding CEO Shah's letter of confirmation, which says once again, the silence does the talking.
There is very little chance that all of this could have flown under the noses of all of these different people and entities, and no one coming from any direction had any knowledge of what was said, or if they did, none were willing to speak up on behalf of themselves or the hardworking businesses they represent.
I'll go as far as saying that nothing is 100%, so there is always a small margin for error, oversight, neglect, or things of the sort; but as far as odds go from here forward, I'd put any odds of denial of the deal as being manufactured or published on behalf of bears, short-sellers and traders long before I'd put any odds on Toron, InMed, or Flagship putting out any form of public statement in denial of all that has long since been mentioned and disseminated.
It has also been stated via press release that Pantheon Partners(parent company of Toron) transfered 100M of its 400M shares of restricted stock to InMed, and another 100M of its 400M shares to Flagship. This would be a 50% reduction in Pantheon's ownership of Toron, with the remaining 50% being awarded in equal parts to two other entities. Who gives away half their company just because it sounds like a fun thing to do? Common sense here.
Backing that up, not only was this publicized via press release, it was also confirmed on the rvom110 account on Nov 27th; and additionally, CEO Morentin of Toron posted a pretty clear statement on his own forum on the company website, not to mention the terms were again validated on the most recent public filing.
Toron has had a stable float of 299M shares for the last 2yrs, coupled with a decrease in A/S, and only a modest increase in restricted O/S to fully satisfy a prior loan to Patienttac, owner and creator of iMedScan, which merged with Toron long before even the mention of InMed ever came about. If we had been seeing dilution of the float, then maybe we could conspire about a sleight of hand in regards to moving around the shares, but there has been no diluting of the float whatsoever.Rationally speaking, if Pantheon gave away half of its shares to InMed and Flagship, with no diluting of the float, plus a decrease of the authorized, it is for a reason. And as mentioned in a prior post, shares belonging to Pantheon, InMed, Flagship and Patienttac, are all restricted O/S, which still fall into the bracket of common shares, such as those belonging to retail, which means that all of these entities share the same fate as the retail investors, good or bad, in terms of value. Long ago, CEO Morentin publicly disclosed that Toron would not be doing a reverse split. The fact the he has given 50% of his ownership stake to the other companies, coupled with the fact that his remaining ownership is still in the form of common shares, as opposed to preferred shares, placing him on the same boat as his shareholders and fellow partnering companies, again places enormously good odds on things, especially when coupled with everything mentioned previously.
The main takeaway here: The silence does the talking.
So getting back to the proof in the silence, there have been a multitude of press releases and updates put out by Toron that mention their dealings with, and acquisition of, InMed. InMed has never once called for a retraction, nor has InMed ever filed suit against Toron, nor has InMed ever issued an independent press release in defense of false claims.
Not only has InMed shown itself comfortable with Toron's disclosures, Flagship has also done the same on the financing end of things. Both InMed and Flagship have signed documentation confirming Toron's public statements, with the respective CEO signatures and letterhead also being posted and shared. No denial or retraction or suit has emerged and been proven legitimate.
Silence has also come in the form of the rvom110 twitter account belonging to the Toron's CEO. https://twitter.com/rvom110/with_replies
The original account for Toron was the IncToron account. I suspect this account will become more active in times to come. https://twitter.com/IncToron/with_replies
Both accounts are mentioned due to the fact that IncToron was mentioned by the rvom110 account in the majority of its Tweets, which would therefore signal an alert which the original Toron could spot from a mile away and blind.
If Rene put out a formal retraction of a falsified PR, there is no way he would not use the IncToron account to publicly claim impersonation on the part of the rvom110 account if it were indeed fraudulent. And to top the evidence in silence off on that part, one of the longs posted a request for verification of the rvom110 account on the Toron website forum. This was posted five days ago, and is obviously monitored by Toron's management. No denial ever came out on behalf of the CEO or company.
So if IncToron is not speaking out against rvom110, nor is the CEO on the company website forum, the silence does the talking. And if InMed has not spoken out in over twelve months of having their deal disclosed and detailed by Toron, nor have they stated falsification of the InMed CEO's letter of confirmation regarding the finalization of the long publicized acquisition, then the silence again does the talking. Additionally, Flagship has not issued any statement or release claiming that Toron's public dissemination of their relationship is false, nor has it done anything similar regarding CEO Shah's letter of confirmation, which says once again, the silence does the talking.
There is very little chance that all of this could have flown under the noses of all of these different people and entities, and no one coming from any direction had any knowledge of what was said, or if they did, none were willing to speak up on behalf of themselves or the hardworking businesses they represent.
I'll go as far as saying that nothing is 100%, so there is always a small margin for error, oversight, neglect, or things of the sort; but as far as odds go from here forward, I'd put any odds of denial of the deal as being manufactured or published on behalf of bears, short-sellers and traders long before I'd put any odds on Toron, InMed, or Flagship putting out any form of public statement in denial of all that has long since been mentioned and disseminated.
It has also been stated via press release that Pantheon Partners(parent company of Toron) transfered 100M of its 400M shares of restricted stock to InMed, and another 100M of its 400M shares to Flagship. This would be a 50% reduction in Pantheon's ownership of Toron, with the remaining 50% being awarded in equal parts to two other entities. Who gives away half their company just because it sounds like a fun thing to do? Common sense here.
Backing that up, not only was this publicized via press release, it was also confirmed on the rvom110 account on Nov 27th; and additionally, CEO Morentin of Toron posted a pretty clear statement on his own forum on the company website, not to mention the terms were again validated on the most recent public filing.
Toron has had a stable float of 299M shares for the last 2yrs, coupled with a decrease in A/S, and only a modest increase in restricted O/S to fully satisfy a prior loan to Patienttac, owner and creator of iMedScan, which merged with Toron long before even the mention of InMed ever came about. If we had been seeing dilution of the float, then maybe we could conspire about a sleight of hand in regards to moving around the shares, but there has been no diluting of the float whatsoever.Rationally speaking, if Pantheon gave away half of its shares to InMed and Flagship, with no diluting of the float, plus a decrease of the authorized, it is for a reason. And as mentioned in a prior post, shares belonging to Pantheon, InMed, Flagship and Patienttac, are all restricted O/S, which still fall into the bracket of common shares, such as those belonging to retail, which means that all of these entities share the same fate as the retail investors, good or bad, in terms of value. Long ago, CEO Morentin publicly disclosed that Toron would not be doing a reverse split. The fact the he has given 50% of his ownership stake to the other companies, coupled with the fact that his remaining ownership is still in the form of common shares, as opposed to preferred shares, placing him on the same boat as his shareholders and fellow partnering companies, again places enormously good odds on things, especially when coupled with everything mentioned previously.
The main takeaway here: The silence does the talking.
ALL THINGS MOBILE ANALYTIC INC. (ATMH) Stock Research Links
Do your own DD. Assume everyone here is either an amateur trader/investor or a paid interest such as a compensated pumper/basher. My posts are strictly for entertainment purposes. I am not on Wall St., do not work for a group, and only get paid when my personal investments materialize. I am only responsible for my own gains and losses; no one is to blame for my mistakes or for any advice taken from postings; likewise, I am not to blame for any advice you take of mine, regardless of gains or losses from doing so. Good luck to all; may you live long and prosper greatly.
